Ethics and the Pharmaceutical Industry and over one million other books are available for Amazon Kindle. Learn more

Vous voulez voir cette page en français ? Cliquez ici.


or
Sign in to turn on 1-Click ordering.
or
Amazon Prime Free Trial required. Sign up when you check out. Learn More
More Buying Choices
Have one to sell? Sell yours here
Start reading Ethics and the Pharmaceutical Industry on your Kindle in under a minute.

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

Ethics and the Pharmaceutical Industry [Hardcover]

Michael A. Santoro , Thomas M. Gorrie

List Price: CDN$ 59.95
Price: CDN$ 47.96 & FREE Shipping. Details
You Save: CDN$ 11.99 (20%)
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
Only 1 left in stock (more on the way).
Ships from and sold by Amazon.ca. Gift-wrap available.
Want it delivered Thursday, October 2? Choose One-Day Shipping at checkout.

Formats

Amazon Price New from Used from
Kindle Edition CDN $17.49  
Hardcover CDN $47.96  
Paperback CDN $29.39  
Save Up to 90% on Textbooks
Hit the books in Amazon.ca's Textbook Store and save up to 90% on used textbooks and 35% on new textbooks. Learn more.
Join Amazon Student in Canada


Book Description

Oct. 31 2005 0521854962 978-0521854962 1
Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Debates are raging over how the industry can and should be expected to act. In this volume leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, marketing and advertising. . Michael Santoro is Associate Professor with tenure in the Business Environment Department at Rutgers Business School, where he teaches courses on business ethics, public policy, labor and human rights, law, ethical issues in the pharmaceutical industry and China business strategy. As a Research Associate at Harvard Business School, he wrote or co-authored nearly thirty case studies and teaching notes on ethical and legal topics such as global protection of intellectual property, insider trading, the Federal Sentencing Guidelines and Fair Credit Reporting Act. Thomas Gorrie is Corporate Vice President, Government Affairs & Policy, at Johnson & Johnson, with responsiblity for all federal, state and international government affairs and policy. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich, following the receipt of his doctorate at Princeton University. Gorrie has over 30 years of worldwide health care experience and has worked with various Johnson & Johnson companies in research and development, marketing and sales, business development, strategic planning, general management, international, venture capital, and health policy.

Customers Who Bought This Item Also Bought


Product Details


Product Description

Review

"Santoro and Gorrieas book tackles one of the most controversial issues affecting our society 'healthcare: an economic commodity or basic human right?' At the heart of this debate is the role of the pharmaceutical industry. The book highlights effectively the opposing forces underlying the tension between the need for financial incentive for drug discovery and the global need for affordable medicines. It succeeds in providing provocative yet balanced perspectives from leaders of industry, government, ethics, business and healthcare. This book is a must read."
-Dr. Victor J. Dzau, President and Chief Executive Officer, Duke University Health System and Chancellor for Health Affairs, Duke University Medical Center

"For intelligent debate on the crisis of confidence in Big Pharma, this volume is unsurpassed. Santoro and Gorrie have assembled an impressive array of voices to tackle contentious issues plaguing the industry, from physician professionalism and research integrity to drug pricing, direct-to-consumer advertising, and intellectual property rights. Combining rigorous analysis with provocative proposals for change, this timely volume should be prescribed reading for industry leaders, policy-makers, and citizens alike."
-Lynn S. Paine, John G. McLean Professor of Business Administration, Harvard Business School

"This book provides thoughtful dialogue from diverse viewpoints on some of the most significant issues in health care -- we need this kind of meaningful dialogue to happen more often."
-Tommy G. Thompson, Former Secretary of Health and Human Services and Former Governor of Wisconsin

"Michael Santoro and Thomas Gorrie have compiled a series of essays that provide a fair, balanced, and insightful examination of an increasingly troubled relationship between the pharmaceutical industry and society."
-Henry Thomas Stelfox, Journal of the American Medical Association

"Ethics and the Pharmaceutical Industry is a timely and thoughtful addition to the growing literature on this controversial subject...I highly recommend this collection of essays as a beginning of a pathway for all parties involved in healthcare."
-Alan T. Kaell, Pharmacy and Therapeutics

"Suffice it to say the book has something in it for almost everyone interested in health care, ethics, and pharmaceuticals. You will learn something from some of the authors, while others will likely make you mad. But they all make you think."
-Merrill Matthews, Journal of the National Association for Business Economics

"Santoro and Gorrie have woven together a rich collection of perspectives in Ethics and the Pharmaceutical Industry, with contributors ranging from activists and academicians to regulators and representatives from the industry."
-Jeremy Sugarman, Johns Hopkins University, The New England Journal of Medicine

"Santoro, Gorrie and their contributors succeed in assembling a text that presents the key issues of business conduct for multinational pharmaceutical corporations, in a spirit of dialogue and respect for truly diverse perspectives."
-William Avery Hudson blog

"A timely and fair-minded overview of many drug-related issues."
-Future Survey

Book Description

Michael A. Santoro, Professor of business ethics, and Thomas M. Gorrie, an industry executive, have invited representatives of government and NGOs, top industry executives, doctors, and scholars to share their views on the most vital and controversial moral issues facing the pharmaceutical industry today. Where do the lines begin and end between the pharmaceutical industry's responsibilitity to society and to its own profit/loss considerations? The authors consider this question across a range of activities, including research and clinical trials, drug pricing, patent protection, and advertising and marketing to doctors and patients.

Inside This Book (Learn More)
First Sentence
 Read the first page
Explore More
Concordance
Browse Sample Pages
Front Cover | Copyright | Table of Contents | Excerpt | Index | Back Cover
Search inside this book:

Customer Reviews

There are no customer reviews yet.
5 star
4 star
3 star
2 star
1 star

Look for similar items by category


Feedback